Problems of clinical trials of new drugs as a basis of modern evidence-based medicine


Cite item

Full Text

Abstract

About the authors

V S Moiseev

V S Moiseev

References

  1. McBride W. Thalidomide and congential abnormalities. Lancet 1961; 2: 1358.
  2. The DAD Study Group. Class of antiretroviral drugs and the risk of myocardial infarction. N. Engl. J. Med. 2007; 356: 1723-1735.
  3. Rubin P., Rutherford J. Drugs therapy in pregnant and breast-feeding women. In: Melmon and morrellis clinical pharmacology. 4 ed. New York: McGraw-Hill; 2000. 1117-1142.
  4. Моисеев В. С., Кобалава Ж. Д. Уроки прерванных клинических исследований в кардиологии. Клин. исслед. лекарств. средств в России 2005; 1-2: 17-19.
  5. The Cardiac Arrhythmia Suppression Trial (CAST) Investigators: effect of encainid and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N. Engl. J. Med. 1989; 321: 406-412.
  6. Elliott C., Abadie R. Exploiting a research underclass in phase 1 clinical trials. N. Engl. J. Med. 2008; 358: 231-236.
  7. Roth B. Drugs and valvular heart disease. N. Engl. J. Med. 2007; 356(1): 6-9.
  8. Schade R., Andersohn F., Suissa A. Dopamine agonists and the risk of cardiac-valve Regurgitation. N. Engl. J. Med. 2007; 356(1): 29-38.
  9. Eichelbaum M., Ingelman-Sundberg M., Evans W. E. Pharmacogenomics and individualized drug therapy. Ann. Rev. Med. 2006; 57: 119-137.
  10. Moore T. J., Cohen M. R., Furberg C. D. Serious adverse drug events reported to the food and drug administration, 1998- 2005. Arch. Intern. Med. 2007; 167: 1752-1759.
  11. Need A. C., Motulsky A. G., Goldstein D. B. Priorities and standards in pharmacogenetic research. Nat. Genet. 2005; 37: 671-681.
  12. Ingelman-Sundberg M. Pharmacogenomic biomarkers for prediction of severe adverse drug reaction. N. Engl. J. Med. 2008; 358(6): 637-639.
  13. Strom R., Kimmel S. Textbook of pharmacoepidemiology. Chichester: Wiley & Sons; 2006.
  14. Avorn J. Dangerous deception - hiding the evidence of adverse drug effects. N. Engl. J. Med. 2006; 355: 2169-2171.
  15. Kjekshus J. et al. Rosuvastatin in older patients with systolic heart failure. N. Engl. J. Med. 2007; 357: 2248-2261.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2008 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 

Address of the Editorial Office:

  • Novij Zykovskij proezd, 3, 40, Moscow, 125167

Correspondence address:

  • Alabyan Street, 13/1, Moscow, 127055, Russian Federation

Managing Editor:

  • Tel.: +7 (926) 905-41-26
  • E-mail: e.gorbacheva@ter-arkhiv.ru

 

 © 2018-2021 "Consilium Medicum" Publishing house


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies